Cannabis FDA gives long-awaited green light to veterans cannabis trial for PTSD After 3 years of negotiating, a cannabis smoking study with 320 American vets is about to kick off Rowan DunneNovember 20, 2024
Medical and Pharmaceutical MIRA Pharma up 27% on ketamine analogue’s preclinical results for chemotherapy pain This pharmaceutical company is also developing a synthetic cannabinoid drug to treat anxiety and cognitive decline Rowan DunneOctober 30, 2024
Cannabis Johns Hopkins study shows synthetic THC helps treat Alzheimer’s It found that patients' agitation was reduced by 30% on average after taking a tablet with the artificial cannabinoid Rowan DunneOctober 4, 2024
Psychedelics Magic mushroom market set to go gangbusters, Irish researcher says By 2029 it will be worth nearly double what it was last year, Research and Markets has predicted Rowan DunneSeptember 20, 2024
Psychedelics Colorado’s first psychedelic church opens its doors Founder Benji “Dez” Dezaval was inspired to help heal others during a powerful psilocybin experience Rowan DunneSeptember 6, 2024
Psychedelics ‘Moms on Mushrooms’ group advocates for micro-dosing, ditching SSRIs "It’s kind of like Facebook, but for moms on shrooms,” the online community founder described Rowan DunneAugust 13, 2024
Psychedelics Kingston psychedelics complex celebrates grand opening The Centre for Psychedelics Health and Research was made possible with a donation from the Ontario Brain Institute Rowan DunneAugust 12, 2024
AI and Autonomy AI therapy app ‘Feeling Great’ makes American debut Feeling Great, inspired by distinguished psychiatrist Dr. David Burns, just raised US$8 million in a seed round Rowan DunneAugust 8, 2024
Psychedelics Google co-founder invests millions in ibogaine research startup Soneira Sergey Brin's Catalyst4 fund, created with capital from his former Tesla stake, will inject over C$20.5 million Rowan DunneJuly 22, 2024
Psychedelics Psychedelic drugs for therapy: history, effectiveness, legal status The Department of Veteran Affairs, or VA, is quietly working on getting ecstasy approved for therapeutic use Adeline EeMay 30, 2024